Selected Publications:
- Ruzicka M, Leenen FHH, Ramsay T, Bugeja A, Edwards C, McCormick B, Hiremath S. Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension. JAMA Intern Med. 2019 Jun 17. doi:10.1001/jamainternmed.2019.1455. [Epub ahead of print] PubMed PMID: 31206124; PubMed Central PMCID: PMC6580437.
- Topf JM, Sparks MA, Phelan PJ, Shah N, Lerma EV, Graham-Brown MP, Madariaga H, Iannuzzella F, Rheault MN, Oates T, Jhaveri KD, Hiremath S. The Evolution of the Journal Club: From Osler to Twitter. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2017; PubMed [journal] PMID: 28233653
- Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials. Am J Kidney Dis. 2016 Oct 3. pii: S0272-6386(16)30420-6. doi: 10.1053/j.ajkd.2016.08.018. PubMed PMID: 27712852.
-
Hiremath S, Knoll G, Weinstein MC. Should the arteriovenous fistula be created before starting dialysis?: a decision analytic approach. PLoS One. 2011;6(12):e28453. PubMed PMID: 22163305; PubMed Central PMCID: PMC3233576.
-
Hiremath S, Akbari A, Shabana W, Fergusson DA, Knoll GA. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One. 2013;8(3):e60009. PubMed PMID: 23555863; PubMed Central PMCID: PMC3608617.
All Other Publications
All Publications:
PEER REVIEWED, PUBLISHED, (*TRAINEE FIRST AUTHOR)
1. *Kidney recovery after iodinated contrast administration in patients with acute kidney injury receiving renal replacement therapy. Khoo B, Friedrich JO, Lebovic G, Hiremath S, Fish-man G, Wing S, Meraz-Munoz A, Harel Z, Goder N, Gal-Oz A, Bagshaw SM, Wald R. J Crit Care. 2025 Jun;87:155015. doi: 10.1016/j.jcrc.2025.155015. Epub 2025 Jan 30. PMID: 39889644
2. Continuous Kidney Replacement Therapies: Core Curriculum 2025. Teixeira JP, Hiremath S, Kabli AO, Rewa OG, Clark EG. Am J Kidney Dis. 2025 Mar 9:S0272-6386(24)01120-X. doi: 10.1053/j.ajkd.2024.09.015. Online ahead of print. PMID: 40072400 Review.
3. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the Ameri-can Heart Association. Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Aro-ra P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, Commodore-Mensah Y, Currie ME, Elkind MSV, Fan W, Generoso G, Gibbs BB, Heard DG, Hiremath S, Johansen MC, Kazi DS, Ko D, Leppert MH, Magnani JW, Michos ED, Mussolino ME, Parikh NI, Perman SM, Rezk-Hanna M, Roth GA, Shah NS, Springer MV, St-Onge MP, Thacker EL, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong ND, Wong SS, Yaffe K, Palaniappan LP; American Heart Association Council on Epidemiology and Prevention Statistics Com-mittee and Stroke Statistics Committee. Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27. PMID: 39866113 Review.
4. Implications of Inaccurate Blood Pressure Measurement on Hypertension Prevalence. Leung AA, Hiremath S, Williams JVA, Tsuyuki RT. CJC Open. 239-246. doi: 10.1016/j.cjco.2024.10.011. eCollection 2025 Feb. PMID: 40060212 Free PMC article.
5. In arterial hypertension, renal denervation vs. a sham procedure reduces ambulatory and office BP at ≤6 mo. Hiremath S; ACP Journal Club Editorial Team at McMaster University. Ann Intern Med. 2025 Feb;178(2):JC17. doi: 10.7326/ANNALS-24-03763-JC. Epub 2025 Feb 4. PMID: 39899875 Clinical Trial.
6. Unentangling Heart Failure From Kidney Outcomes With Finerenone: Insights From the FINEARTS-HF Trial. Kaul S, Hiremath S. J Am Coll Cardiol. 2025 Jan 21;85(2):169-172. doi: 10.1016/j.jacc.2024.11.024. PMID: 39814475 No abstract available.
7. *Definitions of Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients: A Systematic Review Protocol. Wang JZ, Sikora L, Farrell P, Hiremath S, Clark EG. Can J Kidney Health Dis. 2025 Jan 7;12:20543581241312631. doi: 10.1177/20543581241312631. eCollection 2025. PMID: 39776854 Free PMC article.
8. *Protein restriction in CKD: an outdated strategy in the modern era. Bawazir A, Topf JM, Hiremath S. J Bras Nefrol. 2025 Jan-Mar;47(1):e2024PO03. doi: 10.1590/2175-8239-JBN-2024-PO03en. PMID: 39933007 Free PMC article. Review.
9. Hypertension Canada Statement on the use of cuffless blood pressure monitoring devices in clinical practice. Landry C, Dubrofsky L, Pasricha SV, Ringrose J, Ruzicka M, Tran KC, Tsuyuki RT, Hiremath S, Goupil R. Am J Hypertens. 2024 Dec 11:hpae154. doi: 10.1093/ajh/hpae154. Online ahead of print. PMID: 39661401
10. Resistant hypertension. Bugeja A, Hundemer G, Hiremath S. CMAJ. 2024 Jul 28;196(26):E905. doi: 10.1503/cmaj.240206. PMID: 39074865 Free PMC article. No ab-stract available.
11. *Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON. Willows J, Hiremath S. Kidney360. 2024 Jun 1;5(6):795-798. doi: 10.34067/KID.0000000000000344. PMID: 38526155 Free PMC article. No abstract available.
12. Salt and Hypertension: 'Switch'ing the Focus to Potassium. Ruzicka M, Hiremath S. Am J Kidney Dis. 2024 Apr;83(4):546-548. doi: 10.1053/j.ajkd.2023.12.001. Epub 2023 Dec 9. PMID: 38081406 No abstract available..
13. *Blood Pressure Control Should Focus on More Potassium: Controversies in Hypertension. Chan RJ, Parikh N, Ahmed S, Ruzicka M, Hiremath S. Hypertension. 2024 Mar;81(3):501-509. doi: 10.1161/HYPERTENSIONAHA.123.20545. Epub 2023 Aug 29. PMID: 3764192
14. *2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the Amer-ican Heart Association. Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, Commodore-Mensah Y, Currie ME, Elkind MSV, Evenson KR, Generoso G, Heard DG, Hiremath S, Johansen MC, Kalani R, Kazi DS, Ko D, Liu J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Perman SM, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Tsao CW, Urbut SM, Van Spall HGC, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Palaniappan LP; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24. PMID: 38264914 Review.
15. *Potassium and Hypertension: A State-of-the-Art Review. Sriperumbuduri S, Welling P, Ruzicka M, Hundemer GL, Hiremath S. Am J Hypertens. 2024 Jan 16;37(2):91-100. doi: 10.1093/ajh/hpad094. PMID: 37772757
16. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study. Hundemer GL, Agharazii M, Madore F, Vaidya A, Brown JM, Leung AA, Kline GA, Larose E, Piché ME, Crean AM, Shaw JLV, Ramsay T, Hametner B, Wassertheurer S, Sood MM, Hiremath S, Ruzicka M, Goupil R. Circulation. 2024 Jan 9;149(2):124-134. doi: 10.1161/CIRCULATIONAHA.123.066389. Epub 2023 Nov 30. PMID: 38031887 Free PMC article.
17. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. Charchar FJ, Prestes PR, Mills C, Ching SM, Neupane D, Marques FZ, Sharman JE, Vogt L, Burrell LM, Korostovtseva L, Zec M, Patil M, Schultz MG, Wallen MP, Renna NF, Islam SMS, Hiremath S, Gyeltshen T, Chia YC, Gupta A, Schutte AE, Klein B, Borghi C, Brown-ing CJ, Czesnikiewicz-Guzik M, Lee HY, Itoh H, Miura K, Brunström M, Campbell NRC, Akinnibossun OA, Veerabhadrappa P, Wainford RD, Kruger R, Thomas SA, Komori T, Ra-lapanawa U, Cornelissen VA, Kapil V, Li Y, Zhang Y, Jafar TH, Khan N, Williams B, Ster-giou G, Tomaszewski M. J Hypertens. 2024 Jan 1;42(1):23-49. doi: 10.1097/HJH.0000000000003563. Epub 2023 Sep 12. PMID: 37712135 Free PMC article.
18. *Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermit-tent renal replacement therapy: A systematic review. Grewal A, Thabet P, Dubinsky S, Purkayastha D, Wong K, Marko R, Hiremath S, Hutton B, Kanji S. Pharmacotherapy. 2023 Nov;43(11):1206-1220. doi: 10.1002/phar.2861. Epub 2023 Aug 28. PMID: 37596844 Re-view.
19. Social determinants of health and the transition from advanced chronic kidney disease to kidney failure. Hundemer GL, Ravani P, Sood MM, Zimmerman D, Molnar AO, Moorman D, Oliver MJ, White C, Hiremath S, Akbari A. Nephrol Dial Transplant. 2023 Jun 30;38(7):1682-1690. doi: 10.1093/ndt/gfac302. PMID: 36316015 Free PMC article.
20. *Nonadherence Is Common in Patients With Apparent Resistant Hypertension: A Systematic Review and Meta-analysis. Bourque G, Ilin JV, Ruzicka M, Hundemer GL, Shorr R, Hiremath S. Am J Hypertens. 2023 Jun 15;36(7):394-403. doi: 10.1093/ajh/hpad013. PMID: 36715101
21. Giguère P, Deschenes MJ, Loon MV, Hoar S, Fairhead T, Pazhekattu R, Knoll G, Karpinski J, Parikh N, McDougall J, McGuinty M, Hiremath S. Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients. Clin J Am Soc Nephrol. 2023 Apr 26;. doi: 10.2215/CJN.0000000000000186. [Epub ahead of print] PubMed PMID: 37099447.
22. Clark EG, James MT, Hiremath S, Sood MM, Wald R, Garg AX, Silver SA, Tan Z, van Walraven C. Predictive Models for Kidney Recovery and Death in Patients Continuing Di-alysis as Outpatients after Starting in Hospital. Clin J Am Soc Nephrol. 2023 Apr 18;. doi: 10.2215/CJN.0000000000000173. [Epub ahead of print] PubMed PMID: 37071648.
23. Hiremath S, Hundemer GL. Evidence and Uncertainties Surrounding Renin-Guided Medical Therapy for Primary Aldosteronism. Am J Hypertens. 2023 Apr 15;. doi: 10.1093/ajh/hpad034. [Epub ahead of print] PubMed PMID: 37061828.
24. Hiremath S, Blake PG, Yeung A, McGuinty M, Thomas D, Ip J, Brown PA, Pandes M, Burke A, Sohail QZ, To K, Blackwell L, Oliver M, Jain AK, Chagla Z, Cooper R. Early Ex-perience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019. Clin J Am Soc Nephrol. 2023 Apr 1;18(4):485-490. doi: 10.2215/CJN.0000000000000107. Epub 2023 Mar 1. PubMed PMID: 36723285.
25. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2023 Update: A Report from the American Heart Association. Circula-tion. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25. Review. PubMed PMID: 36695182.
26. Cowan AC, Clemens KK, Sontrop JM, Dixon SN, Killin L, Anderson S, Acedillo RR, Bagga A, Bohm C, Brown PA, Cote B, Dev V, Harris C, Hiremath S, Kiaii M, Lacson E Jr, Molnar AO, Oliver MJ, Parmar MS, McRae JM, Nathoo B, Quinn K, Shah N, Silver SA, Tascona DJ, Thompson S, Ting RH, Tonelli M, Vorster H, Wadehra DB, Wald R, Wolf M, Garg AX. Magnesium and Fracture Risk in the General Population and Patients Receiving Dialysis: A Narrative Review. Can J Kidney Health Dis. 2023;10:20543581231154183. doi: 10.1177/20543581231154183. eCollection 2023. Review. PubMed PMID: 36814964; Pub-Med Central PMCID: PMC9940170.
27. Hiremath S. Renalism. CMAJ. 2022 Aug 2;194(29):E1040. doi: 10.1503/cmaj.146430-l. PMID: 35918093; PMCID: PMC9481255.
28. *Bourque G, Hiremath S. Rethinking Resistant Hypertension. J Clin Med. 2022 Mar 7;11(5):1455. doi: 10.3390/jcm11051455. PMID: 35268545; PMCID: PMC8911440.
29. John P, Popa C, Abbasi M, Teakell J, Hiremath S, Willows J. Acetaminophen Exacerbates Hypertension: A #NephJC Editorial on PATH-BP. Kidney Med. 2022 Jun 28;4(8):100515. doi: 10.1016/j.xkme.2022.100515. PMID: 35942504; PMCID: PMC9356292.
30. Trinidad CNB, Hanna MG, Ramesh S, Topf JM, Hiremath S. Lanthanum in Dialysis, the LANDMARK Trial: A #NephJC Editorial. Kidney Med. 2021 Dec 22;4(2):100402. doi: 10.1016/j.xkme.2021.10.014. PMID: 35243312; PMCID: PMC8861954.
31. Hiremath S, McGuinty M, Argyropoulos C, Brimble KS, Brown PA, Chagla Z, Cooper R, Hoar S, Juurlink D, Treleaven D, Walsh M, Yeung A, Blake P. Prescribing Nirma-trelvir/Ritonavir for COVID-19 in Advanced CKD. Clin J Am Soc Nephrol. 2022 Aug;17(8):1247-1250. doi: 10.2215/CJN.05270522. Epub 2022 Jun 9. PMID: 35680135; PMCID: PMC9435977.
32. Bajpai D, Willows JK, Topf JM, Hiremath S. User-generated social media content in knowledge dissemination. Kidney Int. 2022 Dec;102(6):1428-1429. doi: 10.1016/j.kint.2022.09.019. PMID: 36411022.
33. Chellappan A, Kermond R, Caza T, Teakell J, Hiremath S. Steroids for IgA Nephropathy: A #NephJC Editorial on the TESTING trial. Kidney Med. 2022 Nov 1;4(12):100565. doi: 10.1016/j.xkme.2022.100565. PMID: 36438023; PMCID: PMC9681628.
34. *Obeid W, Hiremath S, Topf JM. Protein Restriction for CKD: Time to Move On. Kidney360. 2022 Jun 22;3(9):1611-1615. doi: 10.34067/KID.0001002022. PMID: 36245656; PMCID: PMC9528378.
35. Shimamura Y, Turk M, Qader MA, Shah S, Topf JM, Hiremath S. Potassium- Enriched Salt to Lower Stroke Risk: A #NephJC Editorial on the SSaSS Study. Kidney Med. 2022 May 25;4(7):100489. doi: 10.1016/j.xkme.2022.100489. PMID: 35801189; PMCID: PMC9253645.
36. *Krishnan A, Popa C, John P, Hiremath S, Willows J, Teakell J. Plasma Exchange in Pa-tients With ANCA-Associated Vasculitis: A #NephJC Editorial on a comPLEX Question. Kidney Med. 2022 Aug 25;4(10):100541. doi: 10.1016/j.xkme.2022.100541. PMID: 36159167; PMCID: PMC9490195.
37. Shankar M, Trinidad C, Tannor EK, Hiremath S, Topf JM. Balanced Solutions Versus Saline to Reduce AKI: A #NephJC Editorial on the BaSICS Trial. Kidney Med. 2022 Apr 29;4(6):100472. doi: 10.1016/j.xkme.2022.100472. PMID: 35620080; PMCID: PMC9127688.
38. Macdonald DB, Hurrell CD, Costa AF, McInnes MDF, O'Malley M, Barrett BJ, Brown PA, Clark EG, Hadjivassiliou A, Kirkpatrick IDC, Rempel J, Jeon P, Hiremath S. Canadian As-sociation of Radiologists Guidance on Contrast-Associated Acute Kidney Injury. Can J Kid-ney Health Dis. 2022 May 24;9:20543581221097455. doi: 10.1177/20543581221097455. PMID: 35646375; PMCID: PMC9134018.
39. *Chan RJ, Beaubien-Souligny W, Silver SA, Bagshaw SM, Wald R, Brown PA, Hiremath S, Kong JWY, Clark EG. The Use of I.V. Albumin During Kidney Replacement Therapy: A Survey of Nephrologists and Intensivists. Kidney Int Rep. 2021 Dec 8;7(3):614-617. doi: 10.1016/j.ekir.2021.11.031. PMID: 35257074; PMCID: PMC8897299.
40. Billa V, Noronha S, Bichu S, Kothari J, Kumar R, Mehta K, Jamale T, Bhasin N, Thakare S, Sinha S, Sheth G, Rangaraj N, Pai V, Venugopal A, Toraskar A, Virani Z, Trivedi M, Bajpai D, Khot S, Sirsat R, Almeida A, Hase N, Sundaram, Hariharan, Hiremath S, Chahal IS; ‘Project Victory’ consortium. A Unified Citywide Dashboard for Allocation and Scheduling Dialysis for COVID-19 Patients on Maintenance Hemodialysis. Indian J Nephrol. 2022 May-Jun;32(3):197-205. doi: 10.4103/ijn.IJN_48_21. Epub 2022 Jan 5. PMID: 35814318; PMCID: PMC9267080.
41. Hundemer GL, Ravani P, Sood MM, Zimmerman D, Molnar AO, Moorman D, Oliver MJ, White C, Hiremath S, Akbari A. Social determinants of health and the transition from ad-vanced chronic kidney disease to kidney failure. Nephrol Dial Transplant. 2022 Oct 31:gfac302. doi: 10.1093/ndt/gfac302. Epub ahead of print. PMID: 36316015.
42. Elliott MJ, Ravani P, Quinn RR, Oliver MJ, Love S, MacRae J, Hiremath S, Friesen S, James MT, King-Shier KM. Patient and Clinician Perspectives on Shared Decision Making in Vascular Access Selection: A Qualitative Study. Am J Kidney Dis. 2022 Jul 20:S0272-6386(22)00777-6. doi: 10.1053/j.ajkd.2022.05.016. Epub ahead of print. PMID: 35870570.
43. Hundemer GL, White CA, Norman PA, Knoll GA, Tangri N, Sood MM, Hiremath S, Burns KD, McCudden C, Akbari A. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients. Am J Kidney Dis. 2022 Oct;80(4):462-472.e1. doi: 10.1053/j.ajkd.2022.03.014. Epub 2022 May 16. PMID: 35588905.
44. *Magner K, Ilin JV, Clark EG, Kong JWY, Davis A, Hiremath S. Meta-analytic Techniques to Assess the Association Between N-acetylcysteine and Acute Kidney Injury After Contrast Administration: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Jul 1;5(7):e2220671. doi: 10.1001/jamanetworkopen.2022.20671. PMID: 35788669; PMCID: PMC9257561.
45. Hiremath S, Fergusson D, Knoll G, Ramsay T, Kong J, Ruzicka M. Diet or additional sup-plement to increase potassium intake: protocol for an adaptive clinical trial. Trials. 2022 Feb 14;23(1):147. doi: 10.1186/s13063-022-06071-9. PMID: 35164833.
46. Willows J, Rydzewska-Rosolowska A, Topf JM, Hiremath S. CONFIRMing Hepatorenal Syndrome Management: #NephJC Editorial. Kidney Med. 2021 Aug 19;4(1):100352. doi: 10.1016/j.xkme.2021.07.002. PMID: 35072039; PMCID: PMC8767088.
47. Auguste B, Teakell J, Ullur AR, Topf JM, Hiremath S. Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA. Kidney Med. 2021 Oct 22;3(6):889-892. doi: 10.1016/j.xkme.2021.10.001. PMID: 34938997; PMCID: PMC8664728.
48. Clark EG, McIntyre L, Watpool I, Kong JWY, Ramsay T, Sabri E, Canney M, Hundemer GL, Brown PA, Sood MM, Hiremath S. Intravenous albumin for the prevention of hemodynam-ic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study). Ann Intensive Care. 2021 Dec 13;11(1):174. doi: 10.1186/s13613-021-00962-x. PMID: 34902089; PMCID: PMC8669086
49. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study. Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM. Am J Kidney Dis. 2021 Feb;77(2):178-189.e1. doi: 10.1053/j.ajkd.2020.07.018. Epub 2020 Sep 11.PMID: 32920153
50. *Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kid-ney Replacement Therapy. Hryciw N, Joannidis M, Hiremath S, Callum J, Clark EG. Clin J Am Soc Nephrol. 2021 May 8;16(5):820-828. doi: 10.2215/CJN.09670620. Epub 2020 Oct 28.PMID: 33115729 Review.
51. *Preprint Servers in Kidney Disease Research: A Rapid Review. Vlasschaert C, Giles C, Hiremath S, Lanktree MB. Clin J Am Soc Nephrol. 2021 Mar 8;16(3):479-486. doi: 10.2215/CJN.03800320. Epub 2020 Jul 17.PMID: 32680914 Review.
52. Finerenone: Fiddling With Hyperkalemia? Waitzman J, Canney M, Hiremath S. Am J Kidney Dis. 2021 Aug 11:S0272-6386(21)00789-7. doi: 10.1053/j.ajkd.2021.07.006. Online ahead of print.PMID: 34400243
53. N-Acetylcysteine Interference With Creatinine Measurement: An In Vitro Analysis. McCud-den C, Clark EG, Akbari A, Kong J, Kanji S, Hiremath S. Kidney Int Rep. 2021 Apr 19;6(7):1973-1976. doi: 10.1016/j.ekir.2021.04.006. eCollection 2021 Jul.PMID: 34307992 Free PMC article. No abstract available.
54. CJEM Debate Series: contrast-enhanced imaging should not be withheld for emergency de-partment patients as contrast-induced acute kidney injury is very uncommon. Neilipovitz J, Rosenberg H, Hiremath S, Savage DW, Ohle R, Alaref A, Yadav K, Atkinson P.CJEM. 2021 Jul;23(4):432-436. doi: 10.1007/s43678-021-00126-7. Epub 2021 Apr 3.PMID: 33811636 No abstract available.
55. Blood pressure measurement: Should technique define targets? Hiremath S, Ramsay T, Ruzicka M.J Clin Hypertens (Greenwich). 2021 Aug;23(8):1538-1546. doi: 10.1111/jch.14324. Epub 2021 Jul 16.PMID: 34268883
56. Sex differences in the vascular access of hemodialysis patients: a cohort study. MacRae JM, Clarke A, Ahmed SB, Elliott M, Quinn RR, James M, King-Shier K, Hiremath S, Oliver MJ, Hemmelgarn B, Scott-Douglas N, Ravani P; Alberta Kidney Disease Network. Clin Kidney J. 2020 Sep 6;14(5):1412-1418. doi: 10.1093/ckj/sfaa132. eCollection 2021 May.PMID: 33959269 Free PMC article.
57. *A Systematic Review of the Effect of N-Acetylcysteine on Serum Creatinine and Cystatin C Measurements. Huang JW, Lahey B, Clarkin OJ, Kong J, Clark E, Kanji S, McCudden C, Akbari A, J W Chow B, Shabana W, Hiremath S. Kidney Int Rep. 2020 Dec 3;6(2):396-403. doi: 10.1016/j.ekir.2020.11.018. eCollection 2021 Feb.PMID: 33615065 Free PMC ar-ticle.
58. *Letter to the editor regarding "Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury: a systematic review and meta-analysis of RCT studies". Magner K, Clark E, Hiremath S. Crit Care. 2021 Mar 9;25(1):96. doi: 10.1186/s13054-021-03528-2.PMID: 33750433 Free PMC article. No abstract availa-ble.
59. *Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteron-ism. Hung A, Ahmed S, Gupta A, Davis A, Kline GA, Leung AA, Ruzicka M, Hiremath S, Hundemer GL. J Clin Endocrinol Metab. 2021 Jul 13;106(8):2423-2435. doi: 10.1210/clinem/dgab348.PMID: 34008000
60. Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument. Turgeon RD, Althouse AD, Co-hen JB, Enache B, Hogenesch JB, Johansen ME, Mehta R, Meyerowitz-Katz G, Ziaeian B, Hiremath S. Hypertension. 2021 Sep;78(3):871-878. doi: 10.1161/HYPERTENSIONAHA.121.16501. Epub 2021 Aug 11.PMID: 34379435 No ab-stract available.
61. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease. Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Kidney Int Rep. 2021 Jul 6. doi: 10.1016/j.ekir.2021.06.027. Online ahead of print.PMID: 34250319 Free PMC ar-ticle.
62. Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results? Wurth R, Hajdenberg M, Barrera FJ, Shekhar S, Copaci-no CE, Moreno-Peña PJ, Gharib OAM, Porter F, Hiremath S, Hall JE, Schiffrin EL, Eisen-hofer G, Bornstein SR, Brito JP, González-González JG, Stratakis CA, Rodríguez-Gutiérrez R, Hannah-Shmouni F. Postgrad Med J. 2021 Feb 26:postgradmedj-2020-139392. doi: 10.1136/postgradmedj-2020-139392. Online ahead of print.PMID: 33637639 Free PMC article.
63. Association Between Attempted Arteriovenous Fistula Creation and Mortality in People Start-ing Hemodialysis via a Catheter: A Multicenter, Retrospective Cohort Study. Roberts DJ, Clarke A, Elliott M, King-Shier K, Hiremath S, Oliver M, Quinn RR, Ravani P.Can J Kidney Health Dis. 2021 Jul 30;8:20543581211032846. doi: 10.1177/20543581211032846. eCol-lection 2021.PMID: 34377500 Free PMC article.
64. Canadian Association of Paediatric Nephrologists COVID-19 Rapid Response: Guidelines for Management of Acute Kidney Injury in Children. Alabbas A, Kirpalani A, Morgan C, Mam-men C, Licht C, Phan V, Wade A, Harvey E, Zappitelli M, Clark EG, Hiremath S, Soroka SD, Wald R, Weir MA, Chanchlani R, Lemaire M. Can J Kidney Health Dis. 2021 Feb 5;8:2054358121990135. doi: 10.1177/2054358121990135. eCollection 2021.PMID: 33614056 Free PMC article.
65. *Ashwagandha and Kidney Transplant Rejection. Sriperumbuduri S, Umar MS, Lajoie-Starkell G, Fairhead TR, Hiremath S. Kidney Int Rep. 2020 Oct 3;5(12):2375-2378. doi: 10.1016/j.ekir.2020.09.024. eCollection 2020 Dec.PMID: 33305135 Free PMC article. No abstract available.
66. Albuminuria as a risk factor for acute kidney injury: what is the evidence? Hiremath S, Clark EG.Nephrol Dial Transplant. 2020 Dec 4;35(12):2026-2029. doi: 10.1093/ndt/gfaa276.PMID: 33275760 No abstract available.
67. Resistant Hypertension in a Dialysis Patient. Gallacher PJ, Farrah TE, Dominiczak AF, Touyz RM, Adamczak M, Barigou M, Zoghby Z, Hiremath S, Dhaun N. Hypertension. 2020 Aug;76(2):278-287. doi: 10.1161/HYPERTENSIONAHA.120.15022. Epub 2020 Jun 29.PMID: 32594796 No abstract available.
68. SGLT2 Inhibitors in Resistant Hypertension: A Sweet Solution. Tran KC, Hiremath S. Am J Hypertens. 2020 Dec 31;33(12):1071-1074. doi: 10.1093/ajh/hpaa100.PMID: 32975559 No abstract available.
69. Contrast and acute kidney injury: what is left to enhance? Hiremath S, Kong J, Clark EG. Nephrol Dial Transplant. 2020 Sep 10:gfaa183. doi: 10.1093/ndt/gfaa183. Online ahead of print.PMID: 32909028 No abstract available.
70. *COVID-19 Extrapulmonary illness - The Impact of COVID-19 on Nephrology care. Patel D, Truong T, Shah N, Colbert GB, Thomas B, Velez JCQ, Lerma EV, Hiremath S. Dis Mon. 2020 Sep;66(9):101057. doi: 10.1016/j.disamonth.2020.101057. Epub 2020 Jul 25.PMID: 32758363 Free PMC article. Review.
71. Haemoperfusion should only be used for COVID-19 in the context of randomized trials. Clark EG, Hiremath S, McIntyre L, Wald R, Hundemer GL, Joannidis M. Nat Rev Nephrol. 2020 Dec;16(12):697-699. doi: 10.1038/s41581-020-00352-9.PMID: 32901129 Free PMC article.
72. CSN COVID-19 Rapid Review Program: Management of Acute Kidney Injury. Clark EG, Hiremath S, Soroka SD, Wald R, Weir MA. Can J Kidney Health Dis. 2020 Jul 15;7:2054358120941679. doi: 10.1177/2054358120941679. eCollection 2020.PMID: 32728473 Free PMC article.
73. *Proliferation of Papers and Preprints During the Coronavirus Disease 2019 Pandemic: Pro-gress or Problems With Peer Review? Vlasschaert C, Topf JM, Hiremath S.Adv Chronic Kidney Dis. 2020 Sep;27(5):418-426. doi: 10.1053/j.ackd.2020.08.003. Epub 2020 Aug 6.PMID: 33308508 Free PMC article. Review.
74. Misleading Numbers: Is the Risk of Acute Kidney Injury with COVID-19 Truly This Low?Silver SA, Clark EG, Hiremath S. Am J Nephrol. 2020;51(7):574-575. doi: 10.1159/000508088. Epub 2020 Jun 29.PMID: 32599591 Free PMC article. No abstract available.
75. *Use of the FRAIL Questionnaire in Patients With End-Stage Kidney Disease. Jegatheswa-ran J, Chan R, Hiremath S, Moorman D, Suri RS, Ramsay T, Zimmerman D. Can J Kid-ney Health Dis. 2020 Sep 16;7:2054358120952904. doi: 10.1177/2054358120952904. eCollection 2020.PMID: 32995037 Free PMC article.
76. Effects of CPAP on Blood Pressure and Sympathetic Activity in Patients With Diabetes Mellitus, Chronic Kidney Disease, and Resistant Hypertension. Ruzicka M, Knoll G, Leenen FHH, Leech J, Aaron SD, Hiremath S.nCJC Open. 2020 Mar 27;2(4):258-264. doi: 10.1016/j.cjco.2020.03.010. eCollection 2020 Jul.PMID: 32695977 Free PMC article.
77. *Stoneman S, Hiremath S. Twitter-Based Journal Clubs: Bringing Critical Appraisal to the Social Table. Semin Nephrol. 2020;40(3):264-272. doi:10.1016/j.semnephrol.2020.04.004
78. Sparks MA, South A, Welling P, Luther JM, Cohen J, Byrd JB, Burrell LM, Batlle D, Tomlin-son L, Bhalla V, Rheault MN, Soler MJ, Swaminathan S, Hiremath S. Sound Science be-fore Quick Judgement Regarding RAS Blockade in COVID-19. Clin J Am Soc Nephrol. 2020 May 7;15(5):714-716. doi: 10.2215/CJN.03530320. Epub 2020 Mar 27. PMID: 32220930
79. South AM, Tomlinson L, Edmonston D, Hiremath S, Sparks MA. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol. 2020 Jun;16(6):305-307. doi: 10.1038/s41581-020-0279-4. PMID: 32246101
80. Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, Swaminathan S Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group.
J Am Soc Nephrol. 2020 May 4:ASN.2020040419. doi: 10.1681/ASN.2020040419. Online ahead of print. PMID: 32366514.
81. Kanji S, Roberts JA, Xie J, Zelenitsky S, Hiremath S, Zhang G, Watpool I, Porteous R, Patel R. Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis. Clin Pharmacokinet. 2020 Mar;59(3):327-334. doi: 10.1007/s40262-019-00817-6. PMID: 31471789
82. *Oloko A, Talreja H, Davis A, McCormick B, Clark E, Akbari A, Kong J, Hiremath S. Does Iodinated Contrast Affect Residual Renal Function in Dialysis Patients? A Systematic Re-view and Meta-Analysis. Nephron. 2020;144(4):176-184. doi: 10.1159/000505576. Epub 2020 Mar 10. PMID: 32155642
83. *Amin SO, Ruzicka M, Burns KD, Bence-Bruckler IA, Ryan SE, Hadziomerovic A, Hiremath S. Renovascular hypertension from the BCR-ABL tyrosine kinase inhibitor ponatinib.
aJ Clin Hypertens (Greenwich). 2020 Apr;22(4):678-682. doi: 10.1111/jch.13843. Epub 2020 Mar 16. PMID: 32175644
84. Padwal R, Berg A, Gelfer M, Tran K, Ringrose J, Ruzicka M, Hiremath S. The Hypertension Canada blood pressure device recommendation listing: Empowering use of clinically vali-dated devices in Canada. Accuracy in Measurement of Blood Pressure (AIM-BP) Collabo-rative. J Clin Hypertens (Greenwich). 2020 May;22(5):933-936. doi: 10.1111/jch.13868. Epub 2020 Apr 27. PMID: 32338448No abstract available.
85. *Sriperumbuduri S, Hajjar G, Jetty P, Hiremath S, Ruzicka M. Unintended Consequences: Perils of Renal Revascularization for Severe Hypertension.
Can J Cardiol. 2020 Feb 4:S0828-282X(20)30058-1. doi: 10.1016/j.cjca.2020.01.022. Online ahead of print. PMID: 32389687
86. Alqudsi M, Hiremath S, Velez JCQ. Review - current opinion in cardiology hypertension in chronic kidney disease. Curr Opin Cardiol. 2020 Jul;35(4):360-367. doi: 10.1097/HCO.0000000000000758. PMID: 32487944
87. *Sheikh R, Hiremath S, Clark EG, Akbari A, McCudden C, Brown PA. Bias in the Determi-nation of Dialysate Sodium Concentration Set According to Conductivity Relative to Indi-rect Ion-Selective Measurement Techniques. Kidney Int Rep. 2020 Mar 31;5(6):931-934. doi: 10.1016/j.ekir.2020.03.001. eCollection 2020 Jun. PMID: 32518878.
88. Hiremath S, Velez JCQ. Preventing a nonexistent entity: the curious case of
contrast and acute kidney injury. Curr Opin Nephrol Hypertens. 2020
Jan;29(1):152-160. doi: 10.1097/MNH.0000000000000562. PubMed PMID: 31725007.
89. Mihailidou AS, McCall D, Hiremath S, Costello B, Tunuguntla A, Mihailidis H.
Use of social media at cardiovascular congresses: Opportunities for education and
dissemination. Curr Cardiol Rev. 2020 Feb 5. doi:10.2174/1573403X16666200206103328. [Epub ahead of print] PubMed PMID: 32026782.
90. *Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, Kong
J, Ronco C, Clark EG. Mechanisms for hemodynamic instability related to renal
replacement therapy: a narrative review. Intensive Care Med. 2019
Oct;45(10):1333-1346. doi: 10.1007/s00134-019-05707-w. Epub 2019 Aug 12. Review.
PubMed PMID: 31407042; PubMed Central PMCID: PMC6773820.
91. *Wang C, Hiremath S, Sikora L, Sood MM, Kong J, Clark E. Outpatient kidney
recovery after acute kidney injury requiring dialysis: a systematic review
protocol. Syst Rev. 2019 Aug 22;8(1):214. doi: 10.1186/s13643-019-1134-1. PubMed
PMID: 31439026; PubMed Central PMCID: PMC6706935.
92. Kanji S, Roberts JA, Xie J, Zelenitsky S, Hiremath S, Zhang G, Watpool I,
Porteous R, Patel R. Vancomycin Population Pharmacokinetics in Critically Ill
Adults During Sustained Low-Efficiency Dialysis. Clin Pharmacokinet. 2019 Aug 31.
doi: 10.1007/s40262-019-00817-6. [Epub ahead of print] PubMed PMID: 31471789.
93. *Sriperumbuduri S, Clark E, Hiremath S. New Insights Into Mechanisms of Acute
Kidney Injury in Heart Disease. Can J Cardiol. 2019 Sep;35(9):1158-1169. doi:
10.1016/j.cjca.2019.06.032. Epub 2019 Jul 11. Review. PubMed PMID: 31472814.
94. *Hae R, Samaha D, Brown PA, McQuillan R, Hiremath S, Clark EG. A Survey of
Training for Temporary Hemodialysis Catheter Insertion During Nephrology
Fellowship in Canada: An Update. Can J Kidney Health Dis. 2019 Sep
20;6:2054358119875989. doi: 10.1177/2054358119875989. eCollection 2019. PubMed
PMID: 31565234; PubMed Central PMCID: PMC6755630.
95. Brown PA, Magner PO, Hiremath S, Clark EG. Death due to delirium: a case of a
self-cut hemodialysis dialysis catheter - a case report. BMC Nephrol. 2019 Oct
28;20(1):390. doi: 10.1186/s12882-019-1571-z. PubMed PMID: 31660884; PubMed
Central PMCID: PMC6816152.
96. Ladak F, Ravani P, Oliver MJ, Kamar F, Clarke A, Hiremath S, MacRae J, Blake
P, Moist LM, Garg AX, Lam N, Dumaine C, Quinn RR. The Influence of Age on the
Likelihood of Catheter-Free Fistula Use in Hemodialysis Patients. Can J Kidney
Health Dis. 2019 Jul 30;6:2054358119861943. doi: 10.1177/2054358119861943.
eCollection 2019. PubMed PMID: 31798925; PubMed Central PMCID: PMC6864041.
97. *Bourque G, Ilin JV, Ruzicka M, Davis AS, Hiremath S. The Prevalence of
Nonadherence in Patients With Resistant Hypertension: A Systematic Review
Protocol. Can J Kidney Health Dis. 2019 Dec 25;6:2054358119897196. doi:
10.1177/2054358119897196. eCollection 2019. PubMed PMID: 31903192; PubMed Cen-tral PMCID: PMC6931137.
98. Hiremath S, Ruzicka M, Petrcich W, McCallum MK, Hundemer GL, Tanuseputro P,
Manuel D, Burns K, Edwards C, Bugeja A, Magner P, McCormick B, Garg AX, Rhodes E,
Sood MM. Alpha-Blocker Use and the Risk of Hypotension and Hypotension-Related
Clinical Events in Women of Advanced Age. Hypertension. 2019 Jul
22:HYPERTENSIONAHA11913289. doi: 10.1161/HYPERTENSIONAHA.119.13289. [Epub ahead of print] PubMed PMID: 31327266.
99. *Sriperumbuduri S, Dent R, Malcolm J, Hiremath S, Klein R, White CA, Brown PA,
Akbari A. Accurate GFR in obesity-protocol for a systematic review. Syst Rev.
2019 Jun 22;8(1):147. doi: 10.1186/s13643-019-1052-2. PubMed PMID: 31228953;
PubMed Central PMCID: PMC6588895.
100. Ruzicka M, Leenen FHH, Ramsay T, Bugeja A, Edwards C, McCormick B, Hiremath S.
Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With
Apparent Treatment-Resistant Hypertension. JAMA Intern Med. 2019 Jun 17. doi:
10.1001/jamainternmed.2019.1455. [Epub ahead of print] PubMed PMID: 31206124;
PubMed Central PMCID: PMC6580437.
101. Clark EG, McIntyre L, Ramsay T, Tinmouth A, Knoll G, Brown PA, Watpool I,
Porteous R, Montroy K, Harris S, Kong J, Hiremath S. Saline versus albumin fluid
for extracorporeal removal with slow low-efficiency dialysis (SAFER-SLED): study
protocol for a pilot trial. Pilot Feasibility Stud. 2019 May 30;5:72. doi:
10.1186/s40814-019-0460-3. eCollection 2019. PubMed PMID: 31161046; PubMed
Central PMCID: PMC6542057.
102. Clarke A, Ravani P, Oliver MJ, Hiremath S, Blake PG, Moist LM, Garg AX, Lam
NN, Quinn RR. Timing of Fistula Creation and the Probability of Catheter-Free
Use: A Cohort Study. Can J Kidney Health Dis. 2019 May 7;6:2054358119843139. doi:
10.1177/2054358119843139. eCollection 2019. PubMed PMID: 31105964; PubMed Cen-tral. PMCID: PMC6506926.
103. *Hassan R, Akbari A, Brown PA, Hiremath S, Brimble KS, Molnar AO. Risk Factors
for Unplanned Dialysis Initiation: A Systematic Review of the Literature. Can J
Kidney Health Dis. 2019 Mar 13;6:2054358119831684. doi: 10.1177/2054358119831684.
eCollection 2019. PubMed PMID: 30899532; PubMed Central PMCID: PMC6419254.
104. *Moorman D, Suri R, Hiremath S, Jegatheswaran J, Kumar T, Bugeja A, Zimmerman
D. Benefits and Barriers to and Desired Outcomes with Exercise in Patients with
ESKD. Clin J Am Soc Nephrol. 2019 Jan 29. pii: CJN.09700818. doi:
10.2215/CJN.09700818. [Epub ahead of print] PubMed PMID: 30696660; PubMed Central
PMCID: PMC6390914.
105. Poinen K, Quinn RR, Clarke A, Ravani P, Hiremath S, Miller LM, Blake PG,
Oliver MJ. Complications From Tunneled Hemodialysis Catheters: A Canadian
Observational Cohort Study. Am J Kidney Dis. 2019 Apr;73(4):467-475. doi:
10.1053/j.ajkd.2018.10.014. Epub 2019 Jan 12. PubMed PMID: 30642607.
106. Kamar F, Quinn RR, Oliver MJ, Viecelli AK, Hiremath S, MacRae J, Miller L,
Blake P, Moist L, Garg AX, Lam NN, Kabani R, Clarke A, Liu P, Gillespie B, Ravani
P. Outcomes of the First and Second Hemodialysis Fistula: A Cohort Study. Am J
Kidney Dis. 2019 Jan;73(1):62-71. doi: 10.1053/j.ajkd.2018.06.007. Epub 2018 Aug
16. PubMed PMID: 30122545.
107. *Wang C, Samaha D, Hiremath S, Sikora L, Sood MM, Kanji S, Clark EG. Outcomes after toxic alcohol poisoning: a systematic review protocol. Syst Rev. 2018 Dec 28;7(1):250. doi: 10.1186/s13643-018-0926-z. PubMed PMID: 30593287; PubMed Central PMCID: PMC6309090.
108. Garg AX, Devereaux PJ, Hill A, Sood M, Aggarwal B, Dubois L, Hiremath S, Guzman R, Iyer V, James M, McArthur E, Moist L, Ouellet G, Parikh CR, Schumann V, Sharan S, Thiessen-Philbrook H, Tobe S, Wald R, Walsh M, Weir M, Pannu N. Oral curcumin in elec-tive abdominal aortic aneurysm repair: a multicentre randomized controlled trial. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2018; 190(43):E1273-E1280. PubMed [journal] PMID: 30373740
109. *Douvris A, Zeid K, Hiremath S, Brown PA, Sood MM, Abou Arkoub R, Malhi G, Clark
EG. Safety Lapses Prior to Initiation of Hemodialysis for Acute Kidney Injury in
Hospitalized Patients: A Patient Safety Initiative. Journal of clinical medicine.
2018; 7(10). PubMed [journal] PMID: 30275365, PMCID: PMC6211106
110. Cotie LM, Prince SA, Elliott CG, Ziss MC, McDonnell LA, Mullen KA, Hiremath S,
Pipe AL, Reid RD, Reed JL. The effectiveness of eHealth interventions on physical
activity and measures of obesity among working-age women: a systematic review and me-ta-analysis. Obesity reviews : an official journal of the International
Association for the Study of Obesity. 2018; 19(10):1340-1358. PubMed [journal]
PMID: 30156044
111. *Huang JW, Clarkin OJ, McCudden C, Akbari A, Chow BJW, Shabana W, Kanji S, Davis A, Hiremath S. The Effect of N-Acetylcysteine on Creatinine Measurement: Protocol for a Systematic Review. Canadian journal of kidney health and disease. 2018; 5:2054358118801017. PubMed [journal] PMID: 30263131, PMCID: PMC6156188
112. Kamar F, Quinn RR, Oliver MJ, Viecelli AK, Hiremath S, MacRae J, Miller L, Blake
P, Moist L, Garg AX, Lam NN, Kabani R, Clarke A, Liu P, Gillespie B, Ravani P.
Outcomes of the First and Second Hemodialysis Fistula: A Cohort Study. American
journal of kidney diseases : the official journal of the National Kidney
Foundation. 2018; PubMed [journal] PMID: 30122545
113. *Thangarasa T, Imtiaz R, Hiremath S, Zimmerman D. Physical Activity in Patients
Treated With Peritoneal Dialysis: A Systematic Review and Meta-analysis. Canadian
journal of kidney health and disease. 2018; 5:2054358118779821. PubMed [journal]
PMID: 29977585, PMCID: PMC6024495
114. Colbert GB, Topf J, Jhaveri KD, Oates T, Rheault MN, Shah S, Hiremath S,
Sparks MA. The Social Media Revolution in Nephrology Education. Kidney Int Rep.
2018 Feb 17;3(3):519-529. doi: 10.1016/j.ekir.2018.02.003. eCollection 2018 May.
Review. PubMed PMID: 29854960; PubMed Central PMCID: PMC5976821.
115. McCudden C, Akbari A, White CA, Biyani M, Hiremath S, Brown PA, Tangri N, Brimble
S, Knoll G, Blake PG, Sood MM. Individual patient variability with the
application of the kidney failure risk equation in advanced chronic kidney
disease. PloS one. 2018; 13(6):e0198456. PubMed [journal] PMID: 29894480, PMCID:
PMC5997334
116. Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello
AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S,
Tonelli M, Ravani P. Association between Duration of Predialysis Care and
Mortality after Dialysis Start. Clinical journal of the American Society of
Nephrology : CJASN. 2018; 13(6):893-899. PubMed [journal] PMID: 29507006, PMCID:
PMC5989670
117. Kanji S, Roberts JA, Xie J, Alobaid A, Zelenitsky S, Hiremath S, Zhang G, Watpool
I, Porteous R, Patel R. Piperacillin Population Pharmacokinetics in Critically
Ill Adults During Sustained Low-Efficiency Dialysis. The Annals of
pharmacotherapy. 2018; :1060028018773771. PubMed [journal] PMID: 29730948
118. Brown PA, Hiremath S, Clark EG, Kwok ESH, McCudden C, Akbari A. Implementation
and evaluation of structured nephrology morbidity and mortality conferences: a
quality education report. International urology and nephrology. 2018;
50(5):929-938. PubMed [journal] PMID: 29532307
119. Hiremath S, Akbari A, Wells GA, Chow BJW. Are iso-osmolar, as compared to
low-osmolar, contrast media cost-effective in patients undergoing cardiac
catheterization? An economic analysis. International urology and nephrology.
2018; PubMed [journal] PMID: 29687326
120. Hiremath S, Kayibanda JF, Chow BJW, Fergusson D, Knoll GA, Shabana W, Lahey B,
McBride O, Davis A, Akbari A. Drug discontinuation before contrast procedures and
the effect on acute kidney injury and other clinical outcomes: a systematic
review protocol. Systematic reviews. 2018; 7(1):34. PubMed [journal] PMID:
29467030, PMCID: PMC5822653
121. Ruzicka M, McCormick B, Magner P, Ramsay T, Edwards C, Bugeja A, Hiremath S.
Thiazide diuretic-caused hyponatremia in the elderly hypertensive: will a bottle
of Nepro a day keep hyponatremia and the doctor away? Study protocol for a
proof-of-concept feasibility trial. Pilot and feasibility studies. 2018; 4:71.
PubMed [journal] PMID: 29636984, PMCID: PMC5889541
122. Dumaine C, Kiaii M, Miller L, Moist L, Oliver MJ, Lok CE, Hiremath S, MacRae JM.
Vascular Access Practice Patterns in Canada: A National Survey. Canadian journal
of kidney health and disease. 2018; 5:2054358118759675. PubMed [journal] PMID:
29511569, PMCID: PMC5833215
123. *Douvris A, Malhi G, Hiremath S, McIntyre L, Silver SA, Bagshaw SM, Wald R, Ronco
C, Sikora L, Weber C, Clark EG. Interventions to prevent hemodynamic instability
during renal replacement therapy in critically ill patients: a systematic review.
Critical care (London, England). 2018; 22(1):41. PubMed [journal] PMID: 29467008,
PMCID: PMC5822560
124. *Langote A, Hiremath S, Ruzicka M, McCormick BB. Spironolactone is effective in
treating hypokalemia among peritoneal dialysis patients. PloS one. 2017;
12(11):e0187269. PubMed [journal] PMID: 29125879, PMCID: PMC5681284
125. *Akbari S, Abou-Arkoub R, Sun S, Hiremath S, Reunov A, McCormick BB, Ruzicka M, Burger D. Microparticle Formation in Peritoneal Dialysis: A Proof of Concept Study. Can J Kidney Health Dis. 2017 Mar 22;4:2054358117699829. doi: 10.1177/2054358117699829. eCollection 2017. PubMed PMID: 28540060; PubMed Central PMCID: PMC5433663.
126. *Jegatheswaran J, Ruzicka M, Hiremath S, Edwards C. Are Automated Blood Pressure Monitors Comparable to Ambulatory Blood Pressure Monitors? A Systematic Review and Meta-analysis. Can J Cardiol. 2017 May;33(5):644-652. doi: 10.1016/j.cjca.2017.01.020. Epub 2017 Feb 1. Review. PubMed PMID: 28449834.
127. Sood MM, Akbari A, Manuel D, Ruzicka M, Hiremath S, Zimmerman D, McCormick B, Taljaard M. Time-Varying Association of Individual BP Components with eGFR in Late-Stage CKD. Clin J Am Soc Nephrol. 2017 Jun 7;12(6):904-911. doi: 10.2215/CJN.05640516. Epub 2017 Mar 29. PubMed PMID: 28356338; PubMed Cen-tralPMCID: PMC5460704.
128. *Douvris A, Hiremath S, McIntyre L, Sikora L, Weber C, Clark EG. Interventions to prevent hemodynamic instability during renal replacement therapy for acute kidney injury: a sys-tematic review protocol. Systematic reviews. 2017; 6(1):113. PubMed [journal] PMID: 28619098, PMCID: PMC5472964
129. *Kovacs B, Sullivan KJ, Hiremath S, Patel RV. Effect of sustained low efficient
dialysis versus continuous renal replacement therapy on renal recovery after
acute kidney injury in the intensive care unit: A systematic review and
meta-analysis. Nephrology (Carlton, Vic.). 2017; 22(5):343-353. PubMed [journal]
PMID: 28128881
130. Topf JM, Sparks MA, Phelan PJ, Shah N, Lerma EV, Graham-Brown MP, Madariaga H,
Iannuzzella F, Rheault MN, Oates T, Jhaveri KD, Hiremath S. The Evolution of the
Journal Club: From Osler to Twitter. American journal of kidney diseases : the
official journal of the National Kidney Foundation. 2017; PubMed [journal] PMID:
28233653
131. Mazarova A, Hiremath S, MM Sood, EG Clark, PA Brown, AL Bugeja, Zimmerman D. Hemodialysis Access Choice: Impact of Health Literacy HLRP: Health Literacy Research and Practice 1 (3), e136-e144
132. *Imtiaz R, Hawken S, McCormick BB, Leung S, Hiremath S, Zimmerman DL. Diabetes
Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal
Dialysis Patients. Nutrients. 2017; 9(2). PubMed [journal] PMID: 28218647, PMCID:
PMC5331583
133. Reed JL, Prince SA, Elliott CG, Mullen KA, Tulloch HE, Hiremath S, Cotie LM, Pipe
AL, Reid RD. Impact of Workplace Physical Activity Interventions on Physical
Activity and Cardiometabolic Health Among Working-Age Women: A Systematic Review
and Meta-Analysis. Circulation. Cardiovascular quality and outcomes. 2017; 10(2).
PubMed [journal] PMID: 28228457
134. Quinn RR, Oliver MJ, Devoe D, Poinen K, Kabani R, Kamar F, Mysore P, Lewin AM,
Hiremath S, MacRae J, James MT, Miller L, Hemmelgarn BR, Moist LM, Garg AX,
Chowdhury TT, Ravani P. The Effect of Predialysis Fistula Attempt on Risk of
All-Cause and Access-Related Death. Journal of the American Society of Nephrology
: JASN. 2017; 28(2):613-620. PubMed [journal] PMID: 28143967, PMCID: PMC5280018
135. *Thangarasa T, Imtiaz R, Hiremath S, Zimmerman D. Physical Activity in Patients
Treated With Peritoneal Dialysis: A Protocol for a Systematic Review. Canadian
journal of kidney health and disease. 2017; 4:2054358117695793. PubMed [journal]
PMID: 28321327, PMCID: PMC5347420
136. *Talreja H, Ryan SE, Graham J, Sood MM, Hadziomerovic A, Clark E, Hiremath S.
Endoluminal dilatation for embedded hemodialysis catheters: A case-control study
of factors associated with embedding and clinical outcomes. PloS one. 2017;
12(3):e0174061. PubMed [journal] PMID: 28346468, PMCID: PMC5367692
137. * Mazarova A, Molnar AO, Akbari A, Sood MM, Hiremath S, Burns KD, Ramsay TO,
Mallick R, Knoll GA, Ruzicka M. The association of urinary sodium excretion and
the need for renal replacement therapy in advanced chronic kidney disease: a
cohort study. BMC Nephrol. 2016 Sep 5;17(1):123. doi: 10.1186/s12882-016-0338-z.
PubMed PMID: 27596141; PubMed Central PMCID: PMC5011929.
138. Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA. Renin-Angiotensin
System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients:
A Meta-analysis of Randomized Controlled Trials. Am J Kidney Dis. 2016 Oct 3.
pii: S0272-6386(16)30420-6. doi: 10.1053/j.ajkd.2016.08.018. PubMed PMID:
27712852.
139. Prince SA, Reed JL, Martinello N, Adamo KB, Fodor JG, Hiremath S, Kristjansson EA, Mullen KA, Nerenberg KA, Tulloch HE, Reid RD. Why are adult women physically active? A systematic review of prospective cohort studies to identifyintrapersonal, social environ-mental and physical environmental determinants.Obesity reviews : an official journal of the International Association for theStudy of Obesity. 2016; PubMed [journal] PMID: 27465602
140. Miller LM, MacRae JM, Kiaii M, Clark E, Dipchand C, Kappel J, Lok C, Luscombe R, Moist L, Oliver M, Pike P, Hiremath S. Hemodialysis Tunneled CatheterNoninfectious Complica-tions. Canadian journal of kidney health and disease. 2016;3:2054358116669130. PubMed [journal] PMID: 28270922, PMCID: PMC5332086
141. Miller LM, Clark E, Dipchand C, Hiremath S, Kappel J, Kiaii M, Lok C, Luscombe R,Moist L, Oliver M, MacRae J. Hemodialysis Tunneled Catheter-Related Infections.Canadian journal of kidney health and disease. 2016; 3:2054358116669129. PubMed[journal] PMID: 28270921, PMCID: PMC5332080
142. Clark E, Kappel J, MacRae J, Dipchand C, Hiremath S, Kiaii M, Lok C, Moist L,Oliver M, Miller LM. Practical Aspects of Nontunneled and Tunneled HemodialysisCatheters. Cana-dian journal of kidney health and disease. 2016 3:2054358116669128. PubMed [journal] PMID: 28270920, PMCID: PMC5332079
143. MacRae JM, Dipchand C, Oliver M, Moist L, Yilmaz S, Lok C, Leung K, Clark E, Hiremath S, Kappel J, Kiaii M, Luscombe R, Miller LM. Arteriovenous Access:Infection, Neuropathy, and Other Complications. Canadian journal of kidney healthand disease. 2016; 3:2054358116669127. PubMed [journal] PMID: 28270919, PMCID:PMC5332082
144. MacRae JM, Dipchand C, Oliver M, Moist L, Lok C, Clark E, Hiremath S, Kappel J,Kiaii M, Luscombe R, Miller LM. Arteriovenous Access Failure, Stenosis, andThrombosis. Canadian journal of kidney health and disease. 2016;3:2054358116669126. PubMed [journal] PMID: 28270918, PMCID: PMC5332078
145. MacRae JM, Oliver M, Clark E, Dipchand C, Hiremath S, Kappel J, Kiaii M, Lok C, Lus-combe R, Miller LM, Moist L. Arteriovenous Vascular Access Selection andEvaluation. Ca-nadian journal of kidney health and disease. 2016; 3:2054358116669125. PubMed [journal] PMID: 28270917, PMCID: PMC5332074
146. Molnar AO, Hiremath S, Brown PA, Akbari A. Risk factors for unplanned and crash dialysis starts: a protocol for a systematic review and meta-analysis. Systematic reviews. 2 016; 5(1):117. PubMed [journal] PMID: 27431915, PMCID: PMC4950106
147. Ruzicka M, Akbari A, Bruketa E*, Kayibanda JF, Baril C, Hiremath S. How Accurate Are Home Blood Pressure Devices in Use? A Cross-Sectional Study. PLoSOne. 2016 Jun 1;11(6):e0155677. doi: 10.1371/journal.pone.0155677. eCollection2016. PubMed PMID: 27249056; PubMed Central PMCID: PMC4889144
148. Badve SV, Palmer SC, Strippoli GF, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath SS, Pascoe EM, Perkovic V, Whalley GA, Craig JC,
Johnson DW. The Validity of Left Ventricular Mass as a Surrogate End Point for
All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic
Review and Meta-analysis. Am J Kidney Dis. 2016 Apr 30. pii: S0272-6386(16)30024-5. doi: 10.1053/j.ajkd.2016.03.418. [Epub ahead of print] PubMed PMID: 27138469.
149. *Mace-Brickman T, Leduc W, Hiremath S, Ruzicka M, McCormick BB. Diastolic
Hypotension in a Tertiary Care Hypertension Clinic: Have We Gone Too Far? Can J
Cardiol. 2016 May;32(5):695-700. doi: 10.1016/j.cjca.2015.08.026. Epub 2015 Sep
4. PubMed PMID: 26806792.
150. Clark EG, Akbari A, Hiebert B, Hiremath S, Komenda P, et al. Geographic and facility vari-ation in initial use of non-tunneled catheters for incident maintenance hemodialysis patients. BMC Nephrol. 2016 Feb 27;17(1):20. PubMed PMID: 26920700; PubMed Central PMCID: PMC4769546.
151. Clark EG, Hiremath S. Progressively Earlier Initiation of Renal Replacement Therapy for Acute Kidney Injury Is Unwarranted and Potentially Harmful. Blood Purif. 2016;41(1-3):159-65. PubMed PMID: 26765973.
152. Akbari A, Hladunewich M, Burns K, Moretti F, Arkoub RA, et al. Circulating angiogenic factors in a pregnant woman on intensive hemodialysis: a case report. Can J Kidney Health Dis. 2016;3:7. PubMed PMID: 26909159; PubMed Central PMCID: PMC4763449.
153. Wald R, Adhikari NK, Smith OM, Weir MA, Pope K, Cohen A, Thorpe K, McIntyre L, Lamontagne F, Soth M, Herridge M, Lapinsky S, Clark E, Garg AX, Hiremath S, Klein D, Mazer CD, Richardson RM, Wilcox ME, Friedrich JO, Burns KE, Bagshaw SM. Compari-son of standard and accelerated initiation of renal replacement therapy in acute kidney in-jury. Kidney international. 2015; 88(4):897-904. PubMed [journal] PMID: 26154928
154. Topf JM, Sparks MA, Iannuzzella F, Lerma E, Oates T, Phelan P, Hiremath S Twitter-Based Journal Clubs: Additional Facts and Clarifications. Journal of medical Internet re-search. 2015; 17(9):e216. PubMed [journal] PMID: 26376668
155. Brown PA, Hiremath S. Are There Any Solutions to the Problem of Declining Nephrology Enrolment? A Dialogue Between Two Practicing Nephrologists The Open Journal of Neph-rology and Urology. 8(S2) 59-63. 2015. Doi: 10.2174/1874303X01508010059
156. Chan TM, Thoma B, Radecki R, Topf J, Woo HH, Kao LS, Cochran A, Hiremath S, Lin M. Ten Steps for Setting Up an Online Journal Club. J Contin Educ Health Prof. 2015 Apr;35(2):148-54. doi: 10.1002/chp.21275. PubMed PMID: 26115115
157. Marcel Ruzicka, Tim Ramsay, Ann Bugeja, Cedric Edwards, George Fodor, Anne Kirby, Peter Magner, Brendan McCormick, Gigi van der Hoef, Jessica Wagner, Swapnil Hiremath. Does pragmatically structured outpatient dietary counselling reduce sodium in-take in hypertensive patients? Study protocol for a randomized controlled trial. Trials 2015, 16:273 doi:10.1186/s13063-015-0794-y
158. Brown PA, Akbari A, Molnar AO, Taran S, Bissonnette J, Sood M, Hiremath S Factors As-sociated with Unplanned Dialysis Starts in Patients followed by Nephrologists: A Retrospec-tive Cohort Study. PLoS One. 2015 Jun 5;10(6):e0130080 doi: 10.1371/journal.pone.0130080. eCollection 2015. PubMed PMID: 26047510
159. Thompson K, Razi R, Lee MS, Shen A, Stone GW, Hiremath S, Mehran R, Brar SS. Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: a meta-analysis of 19 randomised trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2015; 11(1). PMID: 25982920
160. Topf JM, Hiremath S. Social media, medicine and the modern journal club. International Review of Psychiatry (Abingdon, England). 2015; 27(2):147-54. PubMed [journal] PMID: 25906989
161. Sood MM, Akbari A, Hiebert B, Hiremath S, Komenda P, Rigatto C, Zimmerman D, Tangri N. Trends in Arteriovenous Fistula Use at Dialysis Initiation After Automated eGFR Report-ing. Seminars in dialysis. 2015; PubMed [journal] PMID: 25583047
162. Hiremath S, Knoll GA, Kayibanda JF, Fergusson D, Chow BJ, Shabana W, Murphy E, Ramsay T, James M, White CA, Garg A, Wald R, Hoch J, Akbari A. Oral salt and water versus intravenous saline for the prevention of acute kidney injury following contrast-enhanced computed tomography: study protocol for a pilot randomized trial. Canadian journal of kidney health and disease. 2015; 2:12. PubMed [journal] PMID: 25883789
163. Reed JL, Prince SA, Cole CA, Fodor JG, Hiremath S, Mullen KA, Tulloch HE, Wright E, Reid RD. Workplace physical activity interventions and moderate-to-vigorous intensity physical activity levels among working-age women: a systematic review protocol. System-atic reviews. 2014; 3:147. PubMed [journal] PMID: 25526769
164. Talreja H, Akbari A, White CA, Ramsay TO, Hiremath S, Knoll G, Predicting kidney trans-plantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014; 64(6):962-8. PubMed [journal] PMID: 25304983
165. Prince SA, Reed JL, Nerenberg KA, Kristjansson EA, Hiremath S, Adamo KB, Tulloch HE, Mullen KA, Fodor JG, Wright E, Reid RD. Intrapersonal, social and physical environmental determinants of moderate-to-vigorous physical activity in working-age women: a systemat-ic review protocol. Systematic reviews. 2014; 3:132. PubMed [journal] PMID: 25370736
166. Kayibanda JF, Hiremath S, Knoll GA, Fergusson D, Chow BJ, Shabana W, Akbari A. Does Intravenous Contrast-enhanced Computed Tomography Cause Acute Kidney Injury? Pro-tocol of a Systematic Review of the Evidence. Syst Rev. 2014 Aug 22; 3:94. PMID 25148933
167. Ruzicka M, Hiremath S, Steiner S, Helis E, Szczotka A, Baker P, Fodor G. What is the feasibility of implementing effective sodium reduction strategies to treat hypertension in primary care settings? A systematic review. J Hypertens. 2014 Apr 2;PubMed PMID: 24694380.
168. *Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW. Effects of uric acid-lowering therapy on renal outcomes: a systematic review and metaanalysis. Nephrol Dial Transplant. 2014 Feb;29(2):406-13. PubMed PMID: 24042021.
169. Ruzicka M, McCormick B, Leenen FH, Froeschl M, Hiremath S. Adherence to blood pres-sure-lowering drugs and resistant hypertension: should trial of direct observation therapy be part of preassessment for renal denervation?. Can J Cardiol. 2013 Dec;29(12):1741.e1-3. PubMed PMID: 2414007
170. Edwards C, Hiremath S, Gupta A, McCormick BB, Ruzicka M. BpTRUth: do automated blood pressure monitors outperform mercury? J Am Soc Hypertens. 2013 Nov-Dec;7(6):448-53. PubMed PMID: 23969286.
171. Hiremath S, Slivar S, Magner P. Phosphate balance with continuous renal replacement therapy: a simple solution. Am J Kidney Dis. 2013 Sep;62(3):644. doi:10.1053/j.ajkd.2013.03.047.
172. Hiremath S, Ruzicka M, Nagaraju SP, McCormick BB. Clinical Hypotension with Co-prescription of Macrolide Antibiotics and Calcium-Channel Blockers in Haemodialysis Pa-tients: A Retrospective Chart Review. Drug Saf. published online 2013 Jul 20
173. Hiremath S, Akbari A, Shabana W, Fergusson DA, Knoll GA. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One. 2013;8(3):e60009
174. *Harman G, Akbari A, Hiremath S, White CA, Ramsay T, Kokolo MB, Craig J, Knoll GA. Accuracy of cystatin C-based estimates of glomerular filtration rate in kidney transplant re-cipients: a systematic review. Nephrol Dial Transplant. 2013 Mar;28(3):741-57. doi: 10.1093/ndt/gfs498
175. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic re-view and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in pa-tients on dialysis. Nephrol Dial Transplant. 2012 Oct;27(10):3816-22. doi: 10.1093/ndt/gfs416.
176. *Chavlovski A, Knoll GA, Ramsay T, Hiremath S, Zimmerman DL. Retrospective review of bone mineral metabolism management in end-stage renal disease patients wait-listed for renal transplant. Transplant Research and Risk Management 09/2012; DOI:10.2147/TRRM.S33577
177. Akbari A, White CA, Shahbazi N, Booth RA, Hiremath S, Knoll GA. Spot Urine Protein Measurements: Are these Accurate in Kidney Transplant Recipients? Transplantation. 2012 Aug 27;94(4):389-395.
178. Xiao F, Hiremath S, Knoll G, Zimpelmann J, Srivaratharajah K, Jadhav D, Fergusson D, Kennedy CR, Burns KD. Increased urinary angiotensin-converting enzyme 2 in renal trans-plant patients with diabetes. PLoS One. 2012;7(5):e37649.
179. Hiremath S, Knoll G, Weinstein MC. Should the Arteriovenous Fistula Be Created before Starting Dialysis?: A Decision Analytic Approach. PLoS One. 2011;6(12):e28453.
180. *Heshka J, Ruzicka M, Hiremath S, McCormick B. Spironolactone is safe and effective for difficult to control hypertension in chronic kidney disease. J Am Soc Hypertension, 2010 Nov-Dec; 4(6):295-301
181. Hiremath S, Punnam SR, Brar SS, Goyal SK, Gardiner JC, Shah AJ, Thakur RK. Implant-able Defibrillators Improve Survival in End-Stage Renal Disease: Results from a Multi-Center Registry. Am J Nephrol 2010;32(4):305-310
182. Hiremath S, Doucette SP, Richardson R, Chan K, Burns K, Zimmerman D. Left ventricular growth after 1 year of haemodialysis does not correlate with arteriovenous access flow: a prospective cohort study. Nephrol Dial Transplant. 2010 Aug; 25(8):2656-61
183. Brar SS, Hiremath S, Dangas G, Mehran R, Brar SK, Leon MB. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Oct;4(10):1584-92.
184. Hiremath S, Holden RM, Fergusson D, Zimmerman DL. Antiplatelet medications in hemo-dialysis patients: a systematic review of bleeding rates. Clin J Am Soc Nephrol. 2009 Aug;4(8):1347-55.
185. Graham J, Hiremath S, Magner PO, Knoll GA, Burns KD: Factors influencing the preva-lence of central venous catheter use in a Canadian haemodialysis centre. Nephrol Dial Transplant. 2008 Nov;23(11):3585-91.
186. Hiremath S, Mulay A, Doucette S, Ferguson D and Knoll G: Renin-Angiotensin System blockade in renal transplant recipients: a systematic review of the evidence, Am J Trans-plant. 2007 Oct;7(10):2350-60.
187. Hiremath S, Biyani M: Technique Survival With Serratia Peritonitis, Adv Perit Dial. 2006;22:73-6.
188. Iyer R, Gupta A, Khan A, Hiremath S, Lokhandwala: Does left ventricular function improve with l-Carnitine after acute myocardial infarction? J Postgrad Med, Apr-Jun 1999 45(2), 38-41.
PUBLISHED GUIDELINES
189. Hypertension Canada's 2020 Evidence Review and Guidelines for the Management of Re-sistant Hypertension. Hiremath S, Sapir-Pichhadze R, Nakhla M, Gabor JY, Khan NA, Kuyper LM, Ruzicka M, Tobe SW, Tran K, Rabi DM, Daskalopoulou SS. Can J Cardiol. 2020 May;36(5):625-634. doi: 10.1016/j.cjca.2020.02.083. PMID: 32389336
190. Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.
Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, To-be SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lind-say P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, Hill MD, Howlett JG, Hundemer GL, Jones C, Kaczorowski J, Khan NA, Kuyper LM, Lamarre-Cliche M, Lavoie KL, Leiter LA, Lewanczuk R, Logan AG, Magee LA, Mangat BK, McFarlane PA, McLean D, Michaud A, Milot A, Moe GW, Penner SB, Pipe A, Poppe AY, Rey E, Roerecke M, Schiffrin EL, Selby P, Sharma M, Shoamanesh A, Si-vapalan P, Townsend RR, Tran K, Trudeau L, Tsuyuki RT, Vallée M, Woo V, Bell AD, Daskalopoulou SS. Can J Cardiol. 2020 May;36(5):596-624. doi: 10.1016/j.cjca.2020.02.086. PMID: 32389335
191. Schieda N, Maralani PJ, Hurrell C, Tsampalieros AK, Hiremath S. Updated
Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney
Disease Issued by the Canadian Association of Radiologists. Can Assoc Radiol J.
2019 Jun 26. pii: S0846-5371(19)30045-2. doi: 10.1016/j.carj.2019.04.001. [Epub
ahead of print] Review. PubMed PMID: 31255393.
192. Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, Jabehdar
Maralani P, Shabana W, Tang A, Tsampalieros A, van der Pol CB, Hiremath S.
Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and
Clinical Practice Guideline Issued by the Canadian Association of Radiologists.
Canadian journal of kidney health and disease. 2018; 5:2054358118778573. PubMed
[journal] PMID: 29977584, PMCID: PMC6024496
193. Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, Jabehdar
Maralani P, Shabana W, Tang A, Tsampalieros A, van der Pol C, Hiremath S.
Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and
Clinical Practice Guideline Issued by the Canadian Association of Radiologists.
Canadian Association of Radiologists journal = Journal l'Association canadienne
des radiologistes. 2018; 69(2):136-150. PubMed [journal] PMID: 29706252
194. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC,
Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G,
McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P,
Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman
RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman
RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL,
Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby
P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L,
Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M,
Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee
LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM,
Daskalopoulou SS. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk
Assessment, Prevention, and Treatment of Hypertension in Adults and Children. The
Canadian journal of cardiology. 2018; 34(5):506-525. PubMed [journal] PMID:
29731013
195. Hypertension Canada’s 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Alexander A Leung, Stella S Daskalopoulou, Kaberi Dasgupta, Kerry McBrien, Sonia Butalia, Kelly B Zarnke, Kara Nerenberg, Kevin C Harris, Meranda Nakhla, Lyne Cloutier, Mark Gelfer, Maxime Lamarre-Cliche, Alain Milot, Peter Bolli, Guy Tremblay, Donna McLean, Sheldon W Tobe, Marcel Ruzicka, Kevin D Burns, Michel Vallée, GV Ramesh Prasad, Steven E Gryn, Ross D Feldman, Peter Selby, Andrew Pipe, Ernesto L Schiffrin, Philip A McFarlane, Paul Oh, Robert A Hegele, Milan Khara, Thomas W Wilson, S Brian Penner, Ellen Burgess, Praveena Sivapalan, Robert J Herman, Simon L Bacon, Simon W Rabkin, Richard E Gilbert, Tavis S Campbell, Steven Grover, George Honos, Patrice Lindsay, Michael D Hill, Shelagh B Coutts, Gord Gubitz, Norman RC Campbell, Gordon W Moe, Jonathan G Howlett, Jean-Martin Boulanger, Ally Prebtani, Gregory Kline, Lawrence A Leiter, Charlotte Jones, Anne Marie Côté, Vincent Woo, Janusz Kaczorowski, Luc Trudeau, Ross T Tsuyuki, Swapnil Hiremath, Denis Drouin, Kim L La-voie, Pavel Hamet, Jean C Grégoire, Richard Lewanczuk, George K Dresser, Mukul Sharma, Debra Reid, Scott A Lear, Gregory Moullec, Milan Gupta, Laura A Magee, Alex-ander G Logan, Janis Dionne, Anne Fournier, Geneviève Benoit, Janusz Feber, Luc Poir-ier, Raj S Padwal, Doreen M Rabi. Publication date: 2017/3/10. Canadian Journal of Cardi-ology http://doi.org/10.1016/j.cjca.2017.03.005
196. Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Tru-deau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanzuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for
Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10. PubMed PMID: 27118291.
197. Daskalopoulou SS, Rabi DM, Zarnke KB , Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczor-owski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS; Canadian Hypertension Education Pro-gram.The 2015 canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hyper-tension. The Canadian journal of cardiology. 2015; 31(5):549-68. PubMed[journal] PMID:25936483
198. Ruzicka M, Quinn RR, McFarlane P, Hemmelgarn B, Ramesh Prasad GV, Feber J, Nesrallah G, Mackinnon M, Tangri N, McCormick B, Tobe S, Blydt-Hansen TD, Hiremath S. Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD. Am J Kidney Dis. 2014 Apr 8;PubMed PMID: 24725980
199. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Car-ruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L, Canadian Hypertension Education Program. The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol. 2014 May;30(5):485-501. PubMed PMID: 24786438
200. Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian association of radiol-ogists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014 May;65(2):96-105. PubMed PMID: 24559602
201. Nesrallah GE, Mustafa RA, Clark WF, Bass A, Barnieh L, Hemmelgarn BR, Klarenbach S, Quinn RR, Hiremath S, Ravani P, Sood MM, Moist LM, Canadian Society of Nephrology. Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. CMAJ. 2014 Feb 4;186(2):112-7. PubMed PMID: 24492525; PubMed Central PMCID: PMC3903737.
PEER REVIEWED EDITORIALS, REVIEWS AND LETTERS TO EDITOR
202. Silver SA, Clark EG, Hiremath S. Misleading Numbers: Is the Risk of Acute Kidney Injury with COVID-19 Truly This Low?. Am J Nephrol. 2020;51(7):574-575. doi:10.1159/000508088
203. Cohen JB, Hanff TC, South AM, Sparks MA, Hiremath S, Bress AP, Byrd JB, Chirinos JA Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angi-otensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".
Circ Res. 2020 Jun 5;126(12):e140-e141. doi: 10.1161/CIRCRESAHA.120.317205. Epub 2020 Jun 4. PMID: 32496917Free PMC article.No abstract available.
204. Clark EG, Hiremath S. INCEPTION: is a larger trial to evaluate intraoperative
renal replacement therapy in liver transplant patients more than just a dream?
Can J Anaesth. 2019 Jul 24. doi: 10.1007/s12630-019-01455-z. [Epub ahead of
print] PubMed PMID: 31342273.
205. Ruzicka M, Hiremath S. Cause, Consequence or confounding? The kidney in
hypertension. J Hum Hypertens. 2019 Apr 16. doi: 10.1038/s41371-019-0199-6. [Epub ahead of print] PubMed PMID: 30992515.
206. Topf JM, Hiremath S. Got CKD? There's an App for That! Clin J Am Soc Nephrol.
2019 Apr 5;14(4):491-492. doi: 10.2215/CJN.02350219. Epub 2019 Mar 21. Pub-Med PMID: 30898874; PubMed Central PMCID: PMC6450351.
207. Sriperumbuduri S, Hiremath S. The case for cautious consumption: NSAIDs in
chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 Mar;28(2):163-170. doi:10.1097/MNH.0000000000000473. PubMed PMID: 30531470.
208. Ruzicka M, Hiremath S. Behind the Mask. Hypertension (Dallas, Tex. : 1979). 2018; 72(4):841-842. PubMed [journal] PMID: 30354729
209. Devireddy C, Hiremath S. Acute Kidney Injury After Transcatheter Aortic Valve Replacement. Circulation. Cardiovascular interventions. 2018; 11(8):e007135. PubMed [journal] PMID: 30354790
210. Hiremath S, Goldfarb DS, Juurlink DN. Opioid Overuse or NSAID Underuse? A Response to the Pain Guide. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2017; 69(6):865. PubMed [journal] PMID: 28454686
211. Ruzicka M, Hiremath S. Accuracy-Limiting Factor of Home Blood Pressure Moni-tors? American journal of hypertension. 2017; 30(7):661-664. PubMed [journal] PMID: 28430845
212. Hiremath S. Towards better blood pressure: Do non-pharmacological strategies
provide the right path? Journal of clinical hypertension (Greenwich, Conn.).
2018; 20(3):528-531. PubMed [journal] PMID: 29450957
213. Ruzicka M, Hiremath S. Intensive blood pressure lowering in chronic kidney dis-ease: the time has come. Current opinion in nephrology and hypertension. 2017 26(3):197-204. PubMed [journal] PMID: 28198732
214. Ruzicka M, Kucharski SE, Hiremath S. Balancing Overscreening and Underdiag-nosis in Secondary Hypertension: The Case of Fibromuscular Dysplasia. Cardiol-ogy clinics. 2017; 35(2):247-254. PubMed [journal] PMID: 28411898
215. Ruzicka M, Burns KD, Hiremath S. Precision Medicine for Hypertension Manage-ment in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease. The Canadian journal of cardiology. 2017; PubMed [journal] PMID: 28365055
216. BB McCormick, S Hiremath, M Ruzicka. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England journal of medicine 374 (23), 2291-2292
217. McCormick BB, Hiremath S, Ruzicka M. Lower blood pressure target in non-diabetic chronic kidney disease is not justified. Kidney Int 2014 Oct; 86(4):855
218. Hiremath S, Edwards C, McCormick BB, Ruzicka M. Reply to Dr Myers' Commen-tary on the Use of Automated Blood Pressure Machines in Office Blood Pressure Measurements. J Clin Hypertens (Greenwich). 2014 May 7;PubMed PMID: 24803307.
219. Hiremath S, Akbari A. Calcium-based phosphate binders and chronic kidney dis-ease. Lancet. 2014 Jan 18;383(9913):216. PubMed PMID: 24439735.
220. Malavade, S Hiremath. Proton pump inhibitors: more indigestion than relief? In-dian Journal of Nephrology. 2017/4 http://www.indianjnephrol.org/preprintarticle.asp?id=202824;type=0
221. Aarti Malavade, Praveen Malavade, Mohan Biyani, Swapnil Hiremath, Ayub Akba-ri. Chronic Kidney Disease in Pregnancy Journal of Integrative Nephrology and Andrology. Year : 2016 | Volume : 3 | Issue : 2 | Page : 48-52
222. Ruzicka M, Hiremath S. Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension. Current hypertension re-ports. 2015; 17(9):579. PubMed [journal] PMID: 26164465
223. Hiremath S, Froeschl M, Ruzicka M. Catheter-based Renal Sympathetic Denerva-tion: Limitations to and Gaps in Evidence. Curr Opin Cardiol 2014 Jul: 29(4):336-43
224. Burns KD, Hiremath S. Urinary angiotensinogen as a biomarker of chronic kidney disease: ready for prime time? Nephrol Dial Transplant. 2012 Aug;27(8):3010-3.
225. Patel MB, Hiremath S, Contractor T, Thakur RK. Implantable Cardioverter-Defibrillators in End-Stage Renal Disease. Cardiac Electrophysiology Clinics Dec 2011; 3 (4), 641-650
226. Hiremath S. Prophylaxis of Contrast-Induced Acute Kidney Injury. Canadian Journal of General Internal Medicine 2010 Aug; 5(2):68-9
227. Hiremath S: Route of Contrast Administration matters. Canadian Medical Associa-tion Journal; Oct 8 2010, (published electronically)
228. Hiremath S, Brar SS. The evidence for sodium bicarbonate therapy for contrast-associated acute kidney injury: far from settled science. Nephrol Dial Transplant. 2010 Aug; 25(8):2802-4
229. Sakhuja R, Shah AJ, Hiremath S, Thakur RK. End-Stage Renal Disease and Sudden Cardiac Death. Cardiac Electrophysiology Clinics December 2009 (Vol. 1, Issue 1, Pages 61-77
230. Hiremath S, Zimmerman D, Knoll G: ACE-inhibitors and Renal failure in Diabetes, Kidney Int. 2006 Oct;70(7):1377
231. Hiremath S, Biyani M: Actinomyces Peritonitis in a Patient on Continuous Cycler Peritoneal Dialysis Perit Dial Int. 2006 Jul-Aug;26(4):513-4
BOOK CHAPTERS
1. Hypertension in the Elderly. Ahmed S, Hiremath S. Kidney Disease in the Elderly (1st Edition) March 2025
2. Device Therapy in Hypertension. Hiremath, S. Hypertension Secrets (2nd edition) March 2022
3. Hypertension and Stroke. Luther, Hiremath S. Hypertension Secrets (2nd edition) March 2022
4. AKI Biomarkers. Hougen I, Clark E, Hiremath S. Issues in Kidney Disease (1st edition) Fall 2021
5. Hypertension in CKD. Farfan-Ruiz A and Hiremath S. Hiremath S. Issues in Kidney Dis-ease (1st edition)
6. History And Physical Diagnosis: S Hiremath, EV Lerma Nephrology Secrets 4th edition, Elsevier Publications, 2018
7. Urinalysis: S Hiremath, Florian Buchkremer, EV Lerma Nephrology Secrets 4th edition, Elsevier Publications, 2018
8. Akbari A and Hiremath S. Contrast induced Acute Kidney Injury: Renal Protection. (1st Edition) Oxford Publications. V Lapsia et al (Editors) Oct 2018
9. Akbari A and Hiremath S. Contrast Nephropathy: Textbook of Critical Care Medicine (7th Edition) Elsevier Publications Editors: Abraham et al Dec 2016
10. Clark EG, Akbari A and Hiremath S. Contrast Nephropathy: Textbook of Critical Care Medicine (8th Edition) Elsevier Publications Editors: Abraham et al Dec 2022
11. Hypertension. Hiremath S. Evidence based Nephrology (Fall 2025 anticipated)
TEXTBOOK EDITOR
• Hypertension Secrets, 2nd edition, Elsevier Publications; published Spring 2022 https://www.elsevier.com/books/hypertension-secrets/lerma/978-0-323-75852-9
